Charlie Sheen's HIV disclosure may reinvigorate awareness, prevention of HIV

February 22, 2016

Actor Charlie Sheen's public disclosure in November 2015 that he has the human immunodeficiency virus (HIV) corresponded with the greatest number of HIV-related Google searches ever recorded in the United States, according to an article published online by JAMA Internal Medicine.

John W. Ayers, Ph.D., M.A., of San Diego State University, California, and coauthors used news and Internet searches to examine engagement with HIV-related topics around the time of Sheen's Nov. 17 disclosure.

The authors used news trends gathered through the Bloomberg Terminal, which included counts of global English-language reports with the term HIV. Internet searches were gathered through Google Trends and included counts of searches originating from the United States for four categories: HIV, condoms, HIV symptoms and HIV testing. Data analysis was conducted from Nov. 17 to Dec. 8, 2015.

The authors report that since 2004, news reports about HIV had decreased from 67 stories per 1,000 to 12 stories per 1,000 in 2015. On the day of Sheen's disclosure, there was a 265 percent increase in news reports mentioning HIV, with more than 6,500 stories on Google News alone, making it among the top 1 percent of HIV-related media days in the past seven years, according to the results.

Sheen's disclosure also corresponded with the greatest number of HIV-related Google searches ever recorded in the United States, according to the research letter. The authors note that about 2.75 million more searches than expected included the term HIV and 1.25 million searches were directly relevant to public health outcomes because they included search terms for condoms, HIV symptoms or HIV testing.

"While no one should be forced to reveal HIV status, Sheen's disclosure may benefit public health by helping many people learn more about HIV infection and prevention. More must be done to make this benefit larger and lasting," the study concludes.
-end-
(JAMA Intern Med. Published online February 22, 2016. doi:10.1001/jamainternmed.2016.0003. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: The study includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Media Advisory: To contact corresponding study author John W. Ayers, Ph.D., M.A., call 619-371-1846 or email ayers.john.w@gmail.com.

The JAMA Network Journals

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.